Sponsor Pipeline

Boehringer Ingelheim Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
96
Active Trials
51
Recruiting
21
Phase 3
10
Disease Areas
49
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07743996
Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary…
Recruitment opened
2026-08-12 NCT05916313
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a…
Enrollment reopened
2026-08-12 NCT05882071
Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use…
date change Primary completion pushed: 2026-07-31 -> 2026-08-31
2026-08-12 NCT05882071
Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use…
date change Completion pushed: 2026-07-31 -> 2026-08-31
2026-08-11 NCT07001475
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality…
Trial completed
2026-08-11 NCT06531824
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With…
Trial sites expanded: 480 -> 497 locations
2026-08-07 NCT06935370
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps…
Trial sites reduced: 632 -> 588 locations
2026-08-07 NCT07220083
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition…
Trial sites expanded: 296 -> 302 locations
2026-08-07 NCT06872892
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With…
date change Primary completion moved earlier: 2028-09-14 -> 2027-06-15
2026-08-07 NCT06872892
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With…
date change Completion moved earlier: 2028-10-12 -> 2027-12-20
2026-08-07 NCT07023354
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…
date change Primary completion pushed: 2026-09-17 -> 2026-12-23
2026-08-07 NCT07023354
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…
date change Completion pushed: 2026-09-17 -> 2026-12-23
2026-08-07 NCT06962839
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic…
Trial sites expanded: 80 -> 89 locations
2026-08-05 NCT05068102
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With…
date change Primary completion moved earlier: 2026-09-16 -> 2026-01-22
2026-08-05 NCT05068102
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With…
date change Completion pushed: 2026-09-16 -> 2027-07-14
2026-08-05 NCT05471856
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are…
date change Completion pushed: 2028-09-13 -> 2029-01-02
2026-08-05 NCT07221591
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are…
Trial completed
2026-08-05 NCT04111458
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in…
date change Primary completion pushed: 2027-12-31 -> 2028-03-31
2026-08-05 NCT04111458
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in…
date change Completion pushed: 2027-12-31 -> 2028-04-30
2026-08-05 NCT05879978
A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With…
date change Completion pushed: 2026-12-31 -> 2027-03-31
Showing 20 of 49 changes detected in the last 30 days.
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-12 NCT07760246 A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart Phase 1 Not Yet Recruiting
2026-08-10 NCT07754461 A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood… Phase 3 Not Yet Recruiting
2026-08-10 NCT07754474 A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in… Phase 1 Not Yet Recruiting
2026-08-04 NCT07743996 Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary… Recruiting
2026-08-04 NCT07744152 A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With… Phase 1 Not Yet Recruiting
2026-07-27 NCT07727785 A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 3
21
Phase 2
17
Phase 1/2
4
Phase 1
42
Not specified
12
Active Trials — top 25 of 96
NCT IDTitleConditionStatus
Phase 3
NCT07361302 A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given… Acute Ischemic Stroke Recruiting
NCT07366034 A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps… Fibrosing Interstitial Lung Disease Recruiting
NCT06238622 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary… Idiopathic Pulmonary Fibrosis Recruiting
NCT06424288 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… Heart Failure Recruiting
NCT06806592 A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic… Interstitial Lung Diseases Recruiting
NCT06872892 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… Bronchiectasis Recruiting
NCT06935370 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… Heart Failure Recruiting
NCT07201922 A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People… Familial Pulmonary Fibrosis Recruiting
NCT07220083 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition… Focal Segmental Glomerulosclerosis Recruiting
NCT07472517 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare… Small Cell Lung Cancer (SCLC) Recruiting
NCT07497087 A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis Systemic Sclerosis Recruiting
NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer… Extrapulmonary Neuroendocrine Cancer (epNEC) Recruiting
NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… Diabetes Mellitus, Type 2 Recruiting
NCT07107945 A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and… Chronic Kidney Disease Recruiting
NCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… Kidney Disease, Chronic Recruiting
NCT06632444 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called… Metabolic Dysfunction Associated Steatohepatitis (MASH) Recruiting
NCT06632457 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver… Metabolic Dysfunction Associated Steatohepatitis Recruiting
NCT07195695 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely… Non-small Cell Lung Cancer Recruiting
NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With… Lung Cancer, Non-squamous, Non-small Cell Active, Not Recruiting
NCT07540988 FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… Interstitial Lung Diseases Not Yet Recruiting
NCT07754461 A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood… Type 2 Diabetes Not Yet Recruiting
Phase 2
NCT05882058 DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small… Small Cell Lung Carcinoma Recruiting
NCT07036523 A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With… Idiopathic Pulmonary Fibrosis Recruiting
NCT06581432 Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced… Solid Tumours Recruiting
NCT07486817 Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced… Lung Cancer, Non-squamous, Non-small Cell Recruiting
See all 96 active Boehringer Ingelheim trials with filters →
Disease Areas
Get alerts when Boehringer Ingelheim's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free